According to the same method described above, AML patients were categorized into high and low expression groups, and the expression of all genes except KLRB1 was correlated with different types of CEBPA mutation, and the expression of SELL and PTPRC was more correlated with different types of CEBPA mutation compared with the other three genes (Table 2). This evidence concerns the gene SELL and acute myeloid leukemia.